Health Care & Life Sciences

WellPoint stock surging on positive analyst forecasts

January 7, 2010
 IBJ Staff and Associated Press
The long-term outlook for health care reform is uncertain, but many analysts are expecting big health insurers like Indianapolis-based WellPoint to benefit in 2010.
More

Hill-Rom hires new CEO

January 7, 2010
 IBJ Staff
John J. Greisch was most recently president of international operations at Baxter International Inc.
More

Witham planning bond sale to acquire Anson site

January 6, 2010
 IBJ Staff
Lebanon-based hospital system also wants to refinance about $21 million in debt on new medical office building.
More

FDA cancels meeting to review Lilly's Cymbalta

January 5, 2010
Associated Press
The agency said the meeting was canceled "to allow time for the FDA to review new information" about a proposed new use for the drug.
More

Health care software firm RealMed regains momentum

January 2, 2010
Peter Schnitzler
RealMed enjoys a nearly 99-percent renewal rate among its current customers and attracted 4,000 new doctors in 2009. Employment at the company is rising after a steady decline.
More

Entrepreneur says quality of venture capital as important as quantity

January 2, 2010
 IBJ Staff
Jim Pearson knows a thing or two about raising money from venture capitalists. And he has some advice for BioCrossroads: Teach entrepreneurs the value of money.
More

Grass-roots groups prepare to fill gaps in health care reform

January 2, 2010
J.K. Wall
Legislation set to come out of Washington will not change the most fundamental problems of the health care system, leaving it up to states, cities and companies to figure out what to do about it.
More

Indiana nears 1M mark in swine-flu vaccinations

December 31, 2009
Associated Press
So far this year, 35 people have died in Indiana from swine flu.
More

St. Francis sues OrthoIndy over new surgery center

December 30, 2009
Peter Schnitzler
Legal complaint alleges new $20 million facility in Greenwood breaches partnership deal struck in 2001.
More

Corporations bet on insiders to bend reform

December 30, 2009
J.K. Wall
Indianapolis health care heavyweights are among those spending $635 million, employing 166 former aides to key congressional leaders and committees in health reform process.
More

Lilly scurries to get out from under Zyprexa cloud

December 26, 2009
J.K. Wall
Another year of rapid change at Eli Lilly and Co. did little to move the company out from under the cloud cast by its best-selling drug, Zyprexa.
More

Health care industry braces for reform

December 26, 2009
J.K. Wall
Congress is on the cusp of transforming health insurance—if it can pass a health reform bill that was losing popularity late in the year.
More

First decade of century marked by buyouts and bubbles

December 26, 2009
J.K. Wall
The decade witnessed a massive terrorist attack, two wars, and a building-and-buyout boom fueled by easy credit.
More

To keep sales force busy, Lilly takes on new drug

December 24, 2009
J.K. Wall
Eli Lilly and Co. has bought the rights to co-market a new cholesterol-fighting drug in the U.S., giving it a third heart drug for sales personnel to push.
More

Investors cheer Senate bill while WellPoint cries foul

December 23, 2009
J.K. Wall
Exemption for not-for-profit health plans could saddle WellPoint with nearly $2 billion a year in new taxes.
More

Conseco raises nearly $223 million in stock offering

December 22, 2009
 IBJ Staff
The Carmel-based life and health insurer immediately applied $161 million of the funds to its bank loans.
More

Lilly pays $90 million for autoimmune drug

December 21, 2009
 IBJ Staff
By acquiring an experimental medicine for rheumatoid arthritis, the Indianapolis-based drugmaker is increasing its focus on autoimmune diseases.
More

First Indiana Future Fund off to a slow startRestricted Content

December 19, 2009
Peter Schnitzler
More than half of the venture capital fund's original investors took a pass on its $58 million successor, the newly launched INext.
More

Setbacks in diabetes market batter Roche

December 19, 2009
J.K. Wall
Roche Diagnostics Corp., once the darling of the U.S. diabetes-device market, is now licking its wounds. And it’s mulling whether to keep fighting on all fronts or to pull back.
More

Judge fines woman waging Web war against plastic surgeon

December 19, 2009
 IBJ Staff
Judge Sarah Evans Barker declared a Massachusetts woman in contempt of court for failing to remove her negative Internet postings about an Indianapolis cosmetic surgeon.
More

Building trades leaders flock to Wishard meetings

December 18, 2009
 IBJ Staff
Hundreds of potential contractors turned out for informational meetings this week about construction work on a new Wishard Memorial Hospital.
More

Hoosier biz groups oppose Senate health bill

December 18, 2009
J.K. Wall
Group presidents tell Indiana senators that the reform bill would expand dysfunctions of current health care systems.
More

Senate rejects drug-importation proposal

December 16, 2009
 IBJ Staff and Associated Press
The U.S. Senate voted down a plan Tuesday to allow Americans to import prescriptions from abroad, handing drug makers such as Indianapolis-based Eli Lilly and Co. a victory.
More

$60M Lilly Endowment grant to fund IU physician research

December 15, 2009
Peter Schnitzler
Indiana University, which has received nearly $600 million from the endowment over the last three decades, will leverage the new gift to increase its scientific discoveries and commercialize life science innovations.
More

Lilly wins approval for long-acting Zyprexa

December 14, 2009
J.K. Wall
Once-a-month injection of best-selling drug will have patents that could extend until 2018.
More
Page  << 71 72 73 74 75 76 77 78 79 80 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. A Tilted Kilt at a water park themed hotel? Who planned that one? I guess the Dad's need something to do while the kids are on the water slides.

  2. Don't come down on the fair for offering drinks. This is a craft and certainly one that belongs in agriculture due to ingredients. And for those worrying about how much you can drink. I'm sure it's more to do with liability than anything else. They don't want people suing for being over served. If you want a buzz, do a little pre-drinking before you go.

  3. I don't drink but go into this "controlled area" so my friend can drink. They have their 3 drink limit and then I give my friend my 3 drink limit. How is the fair going to control this very likely situation????

  4. I feel the conditions of the alcohol sales are a bit heavy handed, but you need to realize this is the first year in quite some time that beer & wine will be sold at the fair. They're starting off slowly to get a gauge on how it will perform this year - I would assume if everything goes fine that they relax some of the limits in the next year or couple of years. That said, I think requiring the consumption of alcohol to only occur in the beer tent is a bit much. That is going to be an awkward situation for those with minors - "Honey, I'm getting a beer... Ok, sure go ahead... Alright see you in just a min- half an hour."

  5. This might be an effort on the part of the State Fair Board to manage the risk until they get a better feel for it. However, the blanket notion that alcohol should not be served at "family oriented" events is perhaps an oversimplification. and not too realistic. For 15 years, I was a volunteer at the Indianapolis Air Show, which was as family oriented an event as it gets. We sold beer donated by Monarch Beverage Company and served by licensed and trained employees of United Package Liquors who were unpaid volunteers. And where did that money go? To central Indiana children's charities, including Riley Hospital for Children! It's all about managing the risk.

ADVERTISEMENT